Patterns of prescription of antipsychotics in Qatar

Author:

Ouanes Sami,Becetti Imen,Ghuloum Suhaila,Hammoudeh Samer,Shehata Mena,Ghabrash Hany,Yehya AreejORCID,Al-Lawati Hawra,Al-Fakhri NoraORCID,Iram Huma,Ajmal Nighat,Eltorki Yassin,Al-Amin HassenORCID

Abstract

Objective Even though all guidelines recommend generally against antipsychotic polypharmacy, antipsychotic polypharmacy appears to be a very common practice across the globe. This study aimed to examine the prescription patterns of antipsychotics in Qatar, in comparison with the international guidelines, and to scrutinize the sociodemographic and clinical features associated with antipsychotic polypharmacy. Methods All the medical records of all the inpatients and outpatients treated by antipsychotics at the Department of Psychiatry–Hamad Medical Corporation (HMC) in Doha, Qatar (between October 2012 and April 2014) were retrospectively analyzed. We retrieved the available sociodemographic data, psychiatric features, and details on the medication history. Results Our sample consisted of 537 individuals on antipsychotics (2/3 were male; mean age 33.8±10.2 years), prescribed for a psychotic disorder in 57%, a mood disorder in 9.3%, and various other diagnoses in 33.7%. About 55.9% received one antipsychotic, 29.6% received two antipsychotics, and 14.5% received more than two antipsychotics. Polypharmacy was associated with younger age (p = 0.025), being single (p<0.001), the diagnosis of a psychotic disorder (p<0.001), and previous admissions to psychiatry (p<0.001). Conclusions Antipsychotic polypharmacy appears to be quite common in Qatar, as it is the case in many other countries, in contrast with most international recommendations. Studies are needed to explore the reasons behind this disparity.

Funder

Qatar National Research Fund

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia;CLM Hui;International review of psychiatry

2. Guidelines for the Pharmacotherapy of Schizophrenia in Adults.;G Remington;Canadian journal of psychiatry Revue canadienne de psychiatrie,2017

3. Antipsychotic polypharmacy: squandering precious resources;SM Stahl;The Journal of clinical psychiatry,2002

4. "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects;SL Young;Journal of psychopharmacology,2015

5. Schizophrenia, neuroleptic medication and mortality;M Joukamaa;The British journal of psychiatry: the journal of mental science,2006

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3